中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2009年
44期
3122-3125
,共4页
刘建%杨小明%刘刚%常连胜%张莉蓉%宋东奎
劉建%楊小明%劉剛%常連勝%張莉蓉%宋東奎
류건%양소명%류강%상련성%장리용%송동규
膀胱肿瘤%多态性%单核苷酸%吸烟%UGT1A7
膀胱腫瘤%多態性%單覈苷痠%吸煙%UGT1A7
방광종류%다태성%단핵감산%흡연%UGT1A7
Urinary bladder neoplasms%Polymorphism%single nucleotide%Smoking%UGT1A7
目的 探讨尿苷二磷酸匍萄糖醛酸转移酶1A7(UGT1A7)基因多态性与膀胱癌易感性的关系.方法 以病例对照研究方法,应用半巢式PCR(SN-PCR)和等位基因特异性PCR(AS-PCR)分别检测208例膀胱癌患者和205例非肿瘤患者的UGT1A7基因多态性,对各基因型和等位基因单独或联合吸烟行为进行统计学分析.结果 膀胱癌组变异纯合基因型[~*x/~*x(x=~*2,~*3,~*4)]的频率(20.7%)高于对照组(12.2%),差异有统计学意义[P<0.05,OR=2.16(1.18~3.96)].膀胱癌组携带变异等位基因~*3的频率(27.9%)高于对照组(20.5%),差异有统计学意义[P=0.009,OR=1.56(95%CI:1.12~2.18)].吸烟人群中,变异杂合基因型[~*1/~*x(x=~*2,~*3,~*4)]或变异纯合基因型者与野生型者相比,膀胱癌组和对照组间差异有统计学意义,OR(95%CI)值分别为2.16(1.07~4.36)、2.64(1.02~6.80).UGT1A7基因多态性与膀胱癌病理分级和临床分期均无相关性(均P>0.05).结论 UGT1A7基因多态性与膀胱癌易感性有关,该基因多态性与吸烟行为在膀胱癌的发生中存在交互作用.
目的 探討尿苷二燐痠匍萄糖醛痠轉移酶1A7(UGT1A7)基因多態性與膀胱癌易感性的關繫.方法 以病例對照研究方法,應用半巢式PCR(SN-PCR)和等位基因特異性PCR(AS-PCR)分彆檢測208例膀胱癌患者和205例非腫瘤患者的UGT1A7基因多態性,對各基因型和等位基因單獨或聯閤吸煙行為進行統計學分析.結果 膀胱癌組變異純閤基因型[~*x/~*x(x=~*2,~*3,~*4)]的頻率(20.7%)高于對照組(12.2%),差異有統計學意義[P<0.05,OR=2.16(1.18~3.96)].膀胱癌組攜帶變異等位基因~*3的頻率(27.9%)高于對照組(20.5%),差異有統計學意義[P=0.009,OR=1.56(95%CI:1.12~2.18)].吸煙人群中,變異雜閤基因型[~*1/~*x(x=~*2,~*3,~*4)]或變異純閤基因型者與野生型者相比,膀胱癌組和對照組間差異有統計學意義,OR(95%CI)值分彆為2.16(1.07~4.36)、2.64(1.02~6.80).UGT1A7基因多態性與膀胱癌病理分級和臨床分期均無相關性(均P>0.05).結論 UGT1A7基因多態性與膀胱癌易感性有關,該基因多態性與吸煙行為在膀胱癌的髮生中存在交互作用.
목적 탐토뇨감이린산포도당철산전이매1A7(UGT1A7)기인다태성여방광암역감성적관계.방법 이병례대조연구방법,응용반소식PCR(SN-PCR)화등위기인특이성PCR(AS-PCR)분별검측208례방광암환자화205례비종류환자적UGT1A7기인다태성,대각기인형화등위기인단독혹연합흡연행위진행통계학분석.결과 방광암조변이순합기인형[~*x/~*x(x=~*2,~*3,~*4)]적빈솔(20.7%)고우대조조(12.2%),차이유통계학의의[P<0.05,OR=2.16(1.18~3.96)].방광암조휴대변이등위기인~*3적빈솔(27.9%)고우대조조(20.5%),차이유통계학의의[P=0.009,OR=1.56(95%CI:1.12~2.18)].흡연인군중,변이잡합기인형[~*1/~*x(x=~*2,~*3,~*4)]혹변이순합기인형자여야생형자상비,방광암조화대조조간차이유통계학의의,OR(95%CI)치분별위2.16(1.07~4.36)、2.64(1.02~6.80).UGT1A7기인다태성여방광암병리분급화림상분기균무상관성(균P>0.05).결론 UGT1A7기인다태성여방광암역감성유관,해기인다태성여흡연행위재방광암적발생중존재교호작용.
Objective To investigate the association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer. Methods Based upon a case-control study, UGT1 A7 polymorphisms were determined by the semi-nested polyrnerase chain reaction (SN-PCR) and allele-specific polymerase chain reaction (AS-PCR) in 208 cases with bladder cancer and 205 non-tumor controls. Risks were evaluated by unconditional logistic regression analysis. Results The frequency of variant homozygous genotype in cases (20.7%) was higher than that in controls (12.2%) and the difference was statistically significant [P < 0.05, OR = 2.16 (1.18-3.96)]. The frequency of variant allele ~*3 in cases was higher than that in controls (27.9%, 20.5% respectively) and the difference was statistically significant [P=0.009, OR = 1.56 (95% CI: 1.12-2.18)]. The smokers with variant homozygous and heterozygous genotypes showed an increased risk of bladder cancer compared with those with wild genotype [2.16 (95% CI: 1.07-4.36), 2.64 (95% CI: 1.02-6.80) respectively]. There was no association between the UGT1A7 polymorphisms and the pathological grade and clinical stage of bladder cancer (both P > 0.05). Conclusion The genetic polymorphisms of UGT1 A7 are associated with the susceptibility of bladder cancer and have interactions with smoking in bladder carcinogenesis.